Abacavir 300 mg
Abacavir 300 mg Tablets are a nucleoside reverse transcriptase inhibitor (NRTI) used as a core component of combination antiretroviral therapy for the management of HIV-1 infection, in line with internationally accepted treatment recommendations.
Product Details
Therapeutic Class
Nucleoside Reverse Transcriptase Inhibitor (NRTI)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
300 mg twice daily or 600 mg once daily, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
60 tablets
Abacavir 300 mg
Abacavir 300 mg Tablets are a nucleoside reverse transcriptase inhibitor (NRTI) used as a core component of combination antiretroviral therapy for the management of HIV-1 infection, in line with internationally accepted treatment recommendations.
Product Details
Therapeutic Class
Nucleoside Reverse Transcriptase Inhibitor (NRTI)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
300 mg twice daily or 600 mg once daily, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
60 tablets
Abacavir 300 mg
Abacavir 300 mg Tablets are a nucleoside reverse transcriptase inhibitor (NRTI) used as a core component of combination antiretroviral therapy for the management of HIV-1 infection, in line with internationally accepted treatment recommendations.
Product Details
Therapeutic Class
Nucleoside Reverse Transcriptase Inhibitor (NRTI)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
300 mg twice daily or 600 mg once daily, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
60 tablets